Logo image of OWLT

OWLET INC (OWLT) Stock Fundamental Analysis

NYSE:OWLT - New York Stock Exchange, Inc. - US69120X2062 - Common Stock - Currency: USD

5.97  -0.13 (-2.13%)

Fundamental Rating

2

Overall OWLT gets a fundamental rating of 2 out of 10. We evaluated OWLT against 188 industry peers in the Health Care Equipment & Supplies industry. OWLT has a bad profitability rating. Also its financial health evaluation is rather negative. OWLT is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

OWLT had negative earnings in the past year.
OWLT had a negative operating cash flow in the past year.
In the past 5 years OWLT always reported negative net income.
In the past 5 years OWLT always reported negative operating cash flow.
OWLT Yearly Net Income VS EBIT VS OCF VS FCFOWLT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M

1.2 Ratios

With a Return On Assets value of -30.18%, OWLT perfoms like the industry average, outperforming 43.09% of the companies in the same industry.
Industry RankSector Rank
ROA -30.18%
ROE N/A
ROIC N/A
ROA(3y)-85.43%
ROA(5y)-66.75%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OWLT Yearly ROA, ROE, ROICOWLT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 500 1K 1.5K

1.3 Margins

Looking at the Gross Margin, with a value of 51.06%, OWLT is in line with its industry, outperforming 45.21% of the companies in the same industry.
OWLT's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for OWLT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 51.06%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.89%
GM growth 5Y1.83%
OWLT Yearly Profit, Operating, Gross MarginsOWLT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

1

2. Health

2.1 Basic Checks

OWLT does not have a ROIC to compare to the WACC, probably because it is not profitable.
OWLT has more shares outstanding than it did 1 year ago.
OWLT has more shares outstanding than it did 5 years ago.
The debt/assets ratio for OWLT has been reduced compared to a year ago.
OWLT Yearly Shares OutstandingOWLT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 5M 10M 15M
OWLT Yearly Total Debt VS Total AssetsOWLT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

Based on the Altman-Z score of -5.63, we must say that OWLT is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -5.63, OWLT is not doing good in the industry: 70.74% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -5.63
ROIC/WACCN/A
WACC10.79%
OWLT Yearly LT Debt VS Equity VS FCFOWLT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M -60M -80M

2.3 Liquidity

OWLT has a Current Ratio of 1.19. This is a normal value and indicates that OWLT is financially healthy and should not expect problems in meeting its short term obligations.
OWLT has a worse Current ratio (1.19) than 84.04% of its industry peers.
A Quick Ratio of 0.90 indicates that OWLT may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.90, OWLT is doing worse than 80.32% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.19
Quick Ratio 0.9
OWLT Yearly Current Assets VS Current LiabilitesOWLT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 93.79% over the past year.
The Revenue has grown by 70.89% in the past year. This is a very strong growth!
OWLT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.40% yearly.
EPS 1Y (TTM)93.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%82.05%
Revenue 1Y (TTM)70.89%
Revenue growth 3Y0.96%
Revenue growth 5Y9.4%
Sales Q2Q%43.05%

3.2 Future

Based on estimates for the next years, OWLT will show a very strong growth in Earnings Per Share. The EPS will grow by 28.78% on average per year.
The Revenue is expected to grow by 26.45% on average over the next years. This is a very strong growth
EPS Next Y-51.02%
EPS Next 2Y33.66%
EPS Next 3Y27.95%
EPS Next 5Y28.78%
Revenue Next Year22.84%
Revenue Next 2Y23.03%
Revenue Next 3Y24.37%
Revenue Next 5Y26.45%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
OWLT Yearly Revenue VS EstimatesOWLT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 50M 100M 150M 200M
OWLT Yearly EPS VS EstimatesOWLT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 -2 -4 -6 -8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

OWLT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for OWLT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OWLT Price Earnings VS Forward Price EarningsOWLT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OWLT Per share dataOWLT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

A more expensive valuation may be justified as OWLT's earnings are expected to grow with 27.95% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.66%
EPS Next 3Y27.95%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for OWLT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OWLET INC

NYSE:OWLT (6/3/2025, 1:29:09 PM)

5.97

-0.13 (-2.13%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)08-11 2025-08-11/amc
Inst Owners49.17%
Inst Owner Change3.07%
Ins Owners8.34%
Ins Owner Change-0.42%
Market Cap98.62M
Analysts82.22
Price Target10.37 (73.7%)
Short Float %2.46%
Short Ratio9.33
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)80.78%
Min EPS beat(2)74.89%
Max EPS beat(2)86.67%
EPS beat(4)4
Avg EPS beat(4)93.46%
Min EPS beat(4)74.89%
Max EPS beat(4)112.26%
EPS beat(8)4
Avg EPS beat(8)-16.31%
EPS beat(12)7
Avg EPS beat(12)-8.05%
EPS beat(16)7
Avg EPS beat(16)-20.76%
Revenue beat(2)2
Avg Revenue beat(2)15.75%
Min Revenue beat(2)14.03%
Max Revenue beat(2)17.47%
Revenue beat(4)3
Avg Revenue beat(4)9.39%
Min Revenue beat(4)-3.53%
Max Revenue beat(4)17.47%
Revenue beat(8)3
Avg Revenue beat(8)-4.12%
Revenue beat(12)3
Avg Revenue beat(12)-5.92%
Revenue beat(16)5
Avg Revenue beat(16)-11.7%
PT rev (1m)0%
PT rev (3m)-32.22%
EPS NQ rev (1m)2.56%
EPS NQ rev (3m)7.32%
EPS NY rev (1m)-1.87%
EPS NY rev (3m)33.68%
Revenue NQ rev (1m)0.95%
Revenue NQ rev (3m)-3.33%
Revenue NY rev (1m)2.47%
Revenue NY rev (3m)2.58%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.99
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.11
EYN/A
EPS(NY)-0.09
Fwd EYN/A
FCF(TTM)-0.88
FCFYN/A
OCF(TTM)-0.84
OCFYN/A
SpS6
BVpS-0.73
TBVpS-0.79
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -30.18%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 51.06%
FCFM N/A
ROA(3y)-85.43%
ROA(5y)-66.75%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.89%
GM growth 5Y1.83%
F-Score5
Asset Turnover1.93
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 176.84%
Cap/Sales 0.82%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.19
Quick Ratio 0.9
Altman-Z -5.63
F-Score5
WACC10.79%
ROIC/WACCN/A
Cap/Depr(3y)95.31%
Cap/Depr(5y)117.31%
Cap/Sales(3y)1.12%
Cap/Sales(5y)1.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)93.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%82.05%
EPS Next Y-51.02%
EPS Next 2Y33.66%
EPS Next 3Y27.95%
EPS Next 5Y28.78%
Revenue 1Y (TTM)70.89%
Revenue growth 3Y0.96%
Revenue growth 5Y9.4%
Sales Q2Q%43.05%
Revenue Next Year22.84%
Revenue Next 2Y23.03%
Revenue Next 3Y24.37%
Revenue Next 5Y26.45%
EBIT growth 1Y2.25%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year111.79%
EBIT Next 3Y37.31%
EBIT Next 5Y29.99%
FCF growth 1Y77.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y78.22%
OCF growth 3YN/A
OCF growth 5YN/A